Company Syngene International Limited
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
730.4 INR | +0.64% |
|
+2.75% | +4.01% |
Business Summary
Number of employees: 6,847
Sales per Business
INR in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Contract Research and Manufacturing Services
96.6
%
| 30,802 | 96.5 % | 33,695 | 96.6 % | +9.39% |
Others
3.3
%
| 1,077 | 3.4 % | 1,158 | 3.3 % | +7.52% |
Scrap
0.1
%
| 50 | 0.2 % | 33 | 0.1 % | -34.00% |
Sales per region
INR in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United States
66.9
%
| 22,918 | 71.8 % | 23,325 | 66.9 % | +1.78% |
Europe
25.2
%
| 5,711 | 17.9 % | 8,775 | 25.2 % | +53.65% |
Rest of the World
4.9
%
| 2,083 | 6.5 % | 1,709 | 4.9 % | -17.95% |
India
3.1
%
| 1,217 | 3.8 % | 1,077 | 3.1 % | -11.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 15-02-28 |
Sibaji Biswas
DFI | Director of Finance/CFO | - | 19-12-17 |
Chairman | 71 | 94-11-17 | |
Compliance Officer | - | 19-07-23 | |
Krishnan G.
IRC | Investor Relations Contact | - | 20-04-30 |
Andrew Webster
HRO | Human Resources Officer | - | 22-11-30 |
Alok Mehrotra
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 94-11-17 | |
Director/Board Member | 67 | 17-07-30 | |
Jonathan Hunt
CEO | Chief Executive Officer | 55 | 15-02-28 |
Kush Parmar
BRD | Director/Board Member | 42 | 21-06-21 |
Paul Blackburn
BRD | Director/Board Member | 70 | 14-08-25 |
Director/Board Member | 63 | 00-08-07 | |
Director/Board Member | 69 | 17-02-28 | |
Director/Board Member | 59 | 19-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 402,536,981 | 179,860,176 ( 44.68 %) | 1,243,697 ( 0.3090 %) | 44.68 % |
Company contact information
Syngene International Ltd.
Biocon Park, Biocon SEZ Bommasandra Indl Area, IV Phase
560099, Bangalore
+91 80 6891 9191
http://www.syngeneintl.com![address Syngene International Limited(SYNGENE)](https://cdn.zonebourse.com/static/address/23365042.png)
Group companies
Name | Category and Sector |
---|---|
Syngene Scientific Solutions Ltd.
|
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.01% | 3.42B | |
+16.59% | 44.44B | |
+41.02% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- SYNGENE Stock
- Company Syngene International Limited